Intrarenal Doppler ultrasonography reflects hemodynamics and predicts prognosis in patients with heart failure.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
17 12 2020
Historique:
received: 20 09 2020
accepted: 08 12 2020
entrez: 18 12 2020
pubmed: 19 12 2020
medline: 5 5 2021
Statut: epublish

Résumé

We aimed to clarify clinical implications of intrarenal hemodynamics assessed by intrarenal Doppler ultrasonography (IRD) and their prognostic impacts in heart failure (HF). We performed a prospective observational study, and examined IRD and measured interlobar renal artery velocity time integral (VTI) and intrarenal venous flow (IRVF) patterns (monophasic or non-monophasic pattern) to assess intrarenal hypoperfusion and congestion in HF patients (n = 341). Seven patients were excluded in VTI analysis due to unclear imaging. The patients were divided into groups based on (A) VTI: high VTI (VTI ≥ 14.0 cm, n = 231) or low VTI (VTI < 14.0 cm, n = 103); and (B) IRVF patterns: monophasic (n = 36) or non-monophasic (n = 305). We compared post-discharge cardiac event rate between the groups, and right-heart catheterization was performed in 166 patients. Cardiac index was lower in low VTI than in high VTI (P = 0.04), and right atrial pressure was higher in monophasic than in non-monophasic (P = 0.03). In the Kaplan-Meier analysis, cardiac event rate was higher in low VTI and monophasic groups (P < 0.01, respectively). In the Cox proportional hazard analysis, the combination of low VTI and a monophasic IRVF pattern was a predictor of cardiac events (P < 0.01). IRD imaging might be associated with cardiac output and right atrial pressure, and prognosis.

Identifiants

pubmed: 33335236
doi: 10.1038/s41598-020-79351-6
pii: 10.1038/s41598-020-79351-6
pmc: PMC7746684
doi:

Substances chimiques

Biomarkers 0

Types de publication

Journal Article Observational Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

22257

Références

Open Heart. 2017 Apr 28;4(1):e000598
pubmed: 28674631
J Am Heart Assoc. 2017 May 16;6(5):
pubmed: 28512114
J Card Fail. 2020 Jul 9;:
pubmed: 32652246
Am J Physiol Heart Circ Physiol. 2017 Oct 1;313(4):H715-H721
pubmed: 28733448
ESC Heart Fail. 2018 Apr;5(2):262-270
pubmed: 28967709
Hypertens Res. 2019 Mar;42(3):319-328
pubmed: 30559403
Annu Rev Physiol. 2003;65:481-500
pubmed: 12524458
J Am Coll Cardiol. 2002 Jun 19;39(12):1901-8
pubmed: 12084586
J Am Coll Cardiol. 2009 Feb 17;53(7):589-596
pubmed: 19215833
Am J Hypertens. 2006 Mar;19(3):282-5
pubmed: 16500514
Eur J Heart Fail. 2020 Apr;22(4):584-603
pubmed: 31908120
J Am Coll Cardiol. 2003 May 21;41(10):1797-804
pubmed: 12767667
JACC Heart Fail. 2017 Sep;5(9):672-681
pubmed: 28711449
Circ J. 2019 Sep 25;83(10):2084-2184
pubmed: 31511439
JACC Heart Fail. 2016 Aug;4(8):683-6
pubmed: 27395345
J Am Coll Cardiol. 2009 Feb 17;53(7):582-588
pubmed: 19215832
Lancet. 1988 May 7;1(8593):1033-5
pubmed: 2896877
Eur Heart J. 2010 Mar;31(6):703-11
pubmed: 20037146
J Am Coll Cardiol. 2013 Aug 6;62(6):485-95
pubmed: 23747781
Circulation. 2013 Oct 15;128(16):1810-52
pubmed: 23741057
J Am Heart Assoc. 2019 Nov 5;8(21):e013584
pubmed: 31630601
Eur Heart J. 2014 Feb;35(7):448-54
pubmed: 24265434
Am J Physiol. 1982 May;242(5):R552-62
pubmed: 7044151
Circulation. 2010 Jul 20;122(3):265-72
pubmed: 20606118
BMJ. 2007 Oct 20;335(7624):806-8
pubmed: 17947786
Am J Physiol. 1980 Apr;238(4):F279-82
pubmed: 7377299
Circ Res. 2014 Jun 20;115(1):79-96
pubmed: 24951759
ESC Heart Fail. 2018 Dec;5(6):1173-1175
pubmed: 30295431
Eur J Heart Fail. 2016 Aug;18(8):891-975
pubmed: 27207191
Int J Cardiol. 2018 May 1;258:269-274
pubmed: 29428236
Eur J Heart Fail. 2016 Apr;18(4):362-71
pubmed: 26694078
J Card Fail. 2012 Dec;18(12):930-8
pubmed: 23207082
Eur J Heart Fail. 2014 Feb;16(2):133-42
pubmed: 24464967
JACC Heart Fail. 2016 Aug;4(8):674-82
pubmed: 27179835
ESC Heart Fail. 2019 Apr;6(2):291-296
pubmed: 30681298
Eur Heart J Acute Cardiovasc Care. 2018 Jun;7(4):330-338
pubmed: 28139135
J Cardiovasc Dev Dis. 2018 Nov 03;5(4):
pubmed: 30400289
J Am Heart Assoc. 2018 Oct 2;7(19):e009961
pubmed: 30371304
Nat Rev Nephrol. 2013 Feb;9(2):99-111
pubmed: 23247571
Lancet. 2019 Nov 23;394(10212):1949-1964
pubmed: 31777389
Br Med J. 1964 Jul 18;2(5402):177
pubmed: 14150898

Auteurs

Akiomi Yoshihisa (A)

Department of Cardiovascular Medicine, Fukushima Medical University, 1 Hikarigaoka, Fukushima, 960-1295, Japan. yoshihis@fmu.ac.jp.

Koichiro Watanabe (K)

Department of Cardiovascular Medicine, Fukushima Medical University, 1 Hikarigaoka, Fukushima, 960-1295, Japan.

Yu Sato (Y)

Department of Cardiovascular Medicine, Fukushima Medical University, 1 Hikarigaoka, Fukushima, 960-1295, Japan.

Shinji Ishibashi (S)

Department of Clinical Laboratory Medicine, Fukushima Medical University, Fukushima, Japan.

Mitsuko Matsuda (M)

Department of Clinical Laboratory Medicine, Fukushima Medical University, Fukushima, Japan.

Yukio Yamadera (Y)

Department of Clinical Laboratory Medicine, Fukushima Medical University, Fukushima, Japan.

Yasuhiro Ichijo (Y)

Department of Cardiovascular Medicine, Fukushima Medical University, 1 Hikarigaoka, Fukushima, 960-1295, Japan.

Tetsuro Yokokawa (T)

Department of Cardiovascular Medicine, Fukushima Medical University, 1 Hikarigaoka, Fukushima, 960-1295, Japan.

Tomofumi Misaka (T)

Department of Cardiovascular Medicine, Fukushima Medical University, 1 Hikarigaoka, Fukushima, 960-1295, Japan.

Masayoshi Oikawa (M)

Department of Cardiovascular Medicine, Fukushima Medical University, 1 Hikarigaoka, Fukushima, 960-1295, Japan.

Atsushi Kobayashi (A)

Department of Cardiovascular Medicine, Fukushima Medical University, 1 Hikarigaoka, Fukushima, 960-1295, Japan.

Yasuchika Takeishi (Y)

Department of Cardiovascular Medicine, Fukushima Medical University, 1 Hikarigaoka, Fukushima, 960-1295, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH